PARTI Our Company We are a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. Following the closing of the Combination described below, we became the sole owner of Pharmagesic (Holdings) Inc. (Pharmagesic) and their wholly owned subsidiary, Wex Pharmaceuticals, Inc. (Wex), and Wexs wholly owned subsidiaries, IWT Bio, Inc. (IWT), Wex Medical Corporation (WMC), and Wex Medical Limited (WML). Our pipeline is focused on treating...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001104659-26-031061 | EDGAR | 77K words |
| 2025-03-31 | 2024-12-31 | 0001558370-25-004167 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0001558370-24-002239 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0001558370-23-003650 | EDGAR | — |
| 2022-03-18 | 2021-12-31 | 0001558370-22-003885 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001558370-21-003366 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001104659-25-108169 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001558370-25-011319 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007109 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001558370-24-014957 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001558370-24-011686 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007713 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018708 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001558370-23-014590 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001558370-23-009516 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017759 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001558370-22-013410 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001558370-22-008661 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-034928 | EDGAR | 1K words |
| 2026-03-18 | 0001104659-26-029992 | EDGAR | — |
| 2026-03-12 | 0001104659-26-027090 | EDGAR | — |
| 2026-01-20 | 0001104659-26-004838 | EDGAR | — |
| 2026-01-13 | 0001104659-26-003211 | EDGAR | — |
| 2025-11-28 | 0001104659-25-116865 | EDGAR | — |
| 2025-11-21 | 0001104659-25-114919 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107471 | EDGAR | — |
| 2025-10-09 | 0001104659-25-098360 | EDGAR | — |
| 2025-09-29 | 0001104659-25-094109 | EDGAR | — |
117 total filings indexed. 89 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001818844 |
| Ticker | DWTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.virios.com |
| Listed | 2020-12-17 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report